PowerUp Acquisition Corp. corrects redemption price by $0.02, plans true-up payment

Aspire Biopharma Holdings, Inc.

Redemption price for May 18, 2023 public share redemption corrected from $10.55 to $10.57 per share.
True-up payment of approximately $0.02 per share to holders of record as of April 19, 2023 who redeemed.
Company expects payment to be made promptly.
Correction stems from notification by Equiniti Trust Company (f/k/a American Stock Transfer & Trust Company).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.